{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:17:58Z","timestamp":1780546678339,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.anndiagpath.2020.151593","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T07:54:05Z","timestamp":1597391645000},"page":"151593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Secondary tumors of the bladder: A survival outcome study"],"prefix":"10.1016","volume":"48","author":[{"given":"Ameer","family":"Hamza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan A.","family":"Czerniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151593_bb0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2559.2000.00797.x","article-title":"Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases","volume":"36","author":"Bates","year":"2000","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151593_bb0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/1066896917741550","article-title":"Secondary malignancies of the bladder: avoiding the diagnostic pitfall","volume":"26","author":"Feldman","year":"2018","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151593_bb0015","first-page":"51","article-title":"Adenocarcinoma of the urinary bladder","volume":"3","author":"Dadhania","year":"2015","journal-title":"Am J Clin Exp Urol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2020.151593_bb0020","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.5858\/2008-132-1417-CCAOUB","article-title":"Clear cell adenocarcinoma of urinary bladder and urethra: another urinary tract lesion immunoreactive for P504S","volume":"132","author":"Sun","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151593_bb0025","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.humpath.2009.10.011","article-title":"Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma","volume":"41","author":"Herawi","year":"2010","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2020.151593_bb0030","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.humpath.2015.07.021","article-title":"Urachal carcinoma: a pathologic and clinical study of 46 cases","volume":"46","author":"Dhillon","year":"2015","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151593_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00292-018-0516-9","article-title":"Urachal cancer-current concepts of a rare cancer","volume":"40","author":"Reis","year":"2019","journal-title":"Pathologe"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151593_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-5347(17)53595-8","article-title":"Tubular urachal remnants in adult bladders","volume":"127","author":"Schubert","year":"1982","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151593_bb0045","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/01.ju.0000054646.49381.01","article-title":"Multimodality management of urachal carcinoma: the MD Anderson Cancer Center experience","volume":"169","author":"Siefker-Radtke","year":"2003","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2020.151593_bb0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0090-4295(85)90112-8","article-title":"Urachal carcinoma","volume":"26","author":"Johnson","year":"1985","journal-title":"Urology"},{"issue":"8","key":"10.1016\/j.anndiagpath.2020.151593_bb0055","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","article-title":"Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151593_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2020.151593_bb0065","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1245\/s10434-012-2709-4","article-title":"Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall surviva in urothelial carcinoma of the bladder","volume":"20","author":"Keck","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151593_bb0070","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.5858\/2003-127-1330-MEILNI","article-title":"Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma","volume":"127","author":"Han","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151593_bb0075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/his.12877","article-title":"Markers of metastatic carcinoma of breast origin","volume":"68","author":"Gown","year":"2016","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151593_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAS.0000000000000524","article-title":"Carcinoma of the uterine cervix involving the genitourinary tract: a potential diagnostic dilemma","volume":"40","author":"Schwartz","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2020.151593_bb0085","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/modpathol.2012.103","article-title":"p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma","volume":"25","author":"Alexander","year":"2012","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2020.151593_bb0090","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/AJCP61KNVHJVHAFN","article-title":"p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma","volume":"132","author":"Nakazawa","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151593_bb0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/his.12769","article-title":"Molecular typing for detection of high-risk human papillomavirus is a useful tool for distinguishing primary bladder carcinoma from secondary involvement of uterine cervical carcinoma in the urinary bladder","volume":"68","author":"Kao","year":"2016","journal-title":"Histopathology"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:32:56Z","timestamp":1761078776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420301362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":19,"alternative-id":["S1092913420301362"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151593","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary tumors of the bladder: A survival outcome study","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151593"}}